相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibiotic resistance of bacterial biofilms
Niels Hoiby et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants
Oana Ciofu et al.
MICROBIOLOGY-SGM (2010)
Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis
M. Kolpen et al.
THORAX (2010)
Antibiotic Resistance in Pseudomonas aeruginosa Strains with Increased Mutation Frequency Due to Inactivation of the DNA Oxidative Repair System
L. F. Mandsberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis
Claus Moser et al.
APMIS (2009)
Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
S. Islam et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Extracellular DNA and F-actin as targets in antibiofilm cystic fibrosis therapy
Tim Tolker-Nielsen et al.
FUTURE MICROBIOLOGY (2009)
Neutrophil Recruitment to the Lungs during Bacterial Pneumonia
Ann Craig et al.
INFECTION AND IMMUNITY (2009)
Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy
Quinn M. Parks et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Pseudomonas aeruginosa Biofilms in the Respiratory Tract of Cystic Fibrosis Patients
Thomas Bjarnsholt et al.
PEDIATRIC PULMONOLOGY (2009)
Increased mutability of Pseudomonas aeruginosa in biofilms
K. Driffield et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
Helle Krogh Johansen et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience
C. R. Hansen et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes
Suenje Johanna Pamp et al.
MOLECULAR MICROBIOLOGY (2008)
Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants
Oana Ciofu et al.
MICROBIOLOGY-SGM (2008)
In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections
Lei Yang et al.
JOURNAL OF BACTERIOLOGY (2008)
Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P-aeruginosa lung infection in Cftr-/- mice
Nadine Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients
Lars Jelsbak et al.
INFECTION AND IMMUNITY (2007)
Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa
Peter O. Jensen et al.
MICROBIOLOGY-SGM (2007)
Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms
Janus A. J. Haagensen et al.
JOURNAL OF BACTERIOLOGY (2007)
Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis
Alessandra Bragonzi et al.
MICROBIOLOGY-SGM (2006)
Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
F Ratjen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection - A case control study
Tacjana Pressler et al.
JOURNAL OF CYSTIC FIBROSIS (2006)
Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections
T Bjarnsholt et al.
MICROBIOLOGY-SGM (2005)
Lower airway inflammation in infants with cystic fibrosis detected by newborn screening
DS Armstrong et al.
PEDIATRIC PULMONOLOGY (2005)
Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis
B Lee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections
MD Maciá et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces
H Matsui et al.
JOURNAL OF IMMUNOLOGY (2005)
Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation
O Ciofu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Novel mouse model of chronic pseudomonas aeruginosa lung infection mimicking cystic fibrosis
N Hoffmann et al.
INFECTION AND IMMUNITY (2005)
Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector
TB Rasmussen et al.
JOURNAL OF BACTERIOLOGY (2005)
Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent
T Bjarnsholt et al.
MICROBIOLOGY-SGM (2005)
Dynamics and spatial distribution of β-lactamase expression in Pseudomonas aeruginosa biofilms
N Bagge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-lactamase and alginate production
N Bagge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Persister cells and tolerance to antimicrobials
I Keren et al.
FEMS MICROBIOLOGY LETTERS (2004)
Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms
G Borriello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion
MD Maciá et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
New concepts of the pathogenesis of cystic fibrosis lung disease
RC Boucher
EUROPEAN RESPIRATORY JOURNAL (2004)
PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A
SM Moskowitz et al.
JOURNAL OF BACTERIOLOGY (2004)
Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa
S Häussler
ENVIRONMENTAL MICROBIOLOGY (2004)
Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis
SM Moskowitz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Inducible nitric oxide synthase (NOS II) is constitutive in human neutrophils
J Cedergren et al.
APMIS (2003)
Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection
ZJ Song et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration -: Lack of association in cystic fibrosis
AL Smith et al.
CHEST (2003)
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis
RL Gibson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways:: rethinking antibiotic treatment strategies and drug targets
DJ Hassett et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Antibodies against β-lactamase can improve ceftazidime treatment of lung infection with β-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection
O Ciofu et al.
APMIS (2002)
Static growth of mucoid Pseudomonas aeruginosa selects for non-mucoid variants that have acquired flagellum-dependent motility
TJO Wyckoff et al.
MICROBIOLOGY-SGM (2002)
Constitutive high expression of chromosomal β-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD
N Bagge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center
M Denton et al.
PEDIATRIC PULMONOLOGY (2002)
Early Intervention in CF Lung Desease: Symposium presented at the 24TH European Cystic Fibrosis Conference, Vienna, June 2001 - Detecting early structural lung damage in cystic fibrosis
HAWM Tiddens
PEDIATRIC PULMONOLOGY (2002)
Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis
DE Geller et al.
CHEST (2002)
The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants
A Oliver et al.
MOLECULAR MICROBIOLOGY (2002)
Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients:: antibiotic resistance, β-lactamase activity and RiboPrinting
O Ciofu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa
K Tateda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth
N Hoiby et al.
MICROBES AND INFECTION (2001)
Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal β-lactamase
N Bagge et al.
APMIS (2000)
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
CK Stover et al.
NATURE (2000)
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
A Oliver et al.
SCIENCE (2000)
The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type
C Moser et al.
APMIS (2000)
Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment
DL MacLeod et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
S Jalal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
